{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:11:56Z","timestamp":1783635116262,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.soc.2006.05.009","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:10:36Z","timestamp":1168423836000},"page":"555-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Malignant Pheochromocytoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Rasa","family":"Zarnegar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Yang","family":"Duh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlo H.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2006.05.009_bib1","series-title":"Textbook of endocrine surgery","author":"Clark","year":"2005"},{"key":"10.1016\/j.soc.2006.05.009_bib2","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/1097-0142(197711)40:5<1987::AID-CNCR2820400502>3.0.CO;2-R","article-title":"One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926\u20131976: a clinicopathological analysis","volume":"40","author":"Melicow","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.009_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF03345810","article-title":"High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991","volume":"15","author":"Proye","year":"1992","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.soc.2006.05.009_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/jnci\/djg024","article-title":"Pheochromocytoma: the expanding genetic differential diagnosis","volume":"95","author":"Bryant","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soc.2006.05.009_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004728-199603000-00028","article-title":"Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb","volume":"20","author":"Neumann","year":"1996","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.soc.2006.05.009_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF02185773","article-title":"No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma","volume":"97","author":"Hofstra","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.soc.2006.05.009_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archsurg.1990.01410190133023","article-title":"Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II","volume":"125","author":"Chevinsky","year":"1990","journal-title":"Arch Surg"},{"key":"10.1016\/j.soc.2006.05.009_bib8","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.soc.2006.05.009_bib9","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1034\/j.1600-0463.2003.1110402.x","article-title":"VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome","volume":"111","author":"Salmenkivi","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.soc.2006.05.009_bib10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/01.HYP.36.6.1045","article-title":"Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment","volume":"36","author":"Rao","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.soc.2006.05.009_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome","volume":"11","author":"Eisenhofer","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.soc.2006.05.009_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/ejso.2002.1413","article-title":"The management of benign and malignant pheochromocytoma and abdominal paraganglioma","volume":"29","author":"Edstrom Elder","year":"2003","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.soc.2006.05.009_bib13","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.287.11.1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best?","volume":"287","author":"Lenders","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.soc.2006.05.009_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/eje.0.1470085","article-title":"The value of plasma markers for the clinical behaviour of phaeochromocytomas","volume":"147","author":"van der Harst","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.soc.2006.05.009_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","article-title":"Pheochromocytomas: can malignant potential be predicted?","volume":"53","author":"John","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.soc.2006.05.009_bib16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.HYP.29.5.1133","article-title":"Tumor recurrence and hypertension persistence after successful pheochromocytoma operation","volume":"29","author":"Plouin","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.soc.2006.05.009_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2214\/ajr.146.4.741","article-title":"Pheochromocytoma: detection by unenhanced CT","volume":"146","author":"Radin","year":"1986","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.soc.2006.05.009_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2342031876","article-title":"Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT","volume":"234","author":"Szolar","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.soc.2006.05.009_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00007611-198602000-00025","article-title":"Thoracic pheochromocytoma: computerized tomographic characteristics","volume":"79","author":"Shin","year":"1986","journal-title":"South Med J"},{"key":"10.1016\/j.soc.2006.05.009_bib20","first-page":"188","article-title":"Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques","volume":"48","author":"Maurea","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2006.05.009_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000173960","article-title":"131I-MIBG\u2013a new agent in diagnosis and treatment of pheochromocytoma","volume":"72","author":"Shapiro","year":"1985","journal-title":"Cardiology"},{"key":"10.1016\/j.soc.2006.05.009_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.2002.tb04423.x","article-title":"Diagnostic localization of pheochromocytoma: the coming of age of positron emission tomography","volume":"970","author":"Pacak","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.soc.2006.05.009_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","article-title":"Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites","volume":"27","author":"Mamede","year":"2006","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.soc.2006.05.009_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0046-8177(98)90070-3","article-title":"Prognostic markers in pheochromocytoma","volume":"29","author":"Clarke","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/(SICI)1096-9896(200006)191:2<175::AID-PATH615>3.0.CO;2-Z","article-title":"Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?","volume":"191","author":"van der Harst","year":"2000","journal-title":"J Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","author":"Goldstein","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2006.05.009_bib27","first-page":"1160","article-title":"Comparison of adrenal and extra-adrenal pheochromocytomas","volume":"114","author":"Pommier","year":"1993","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2006.05.009_bib28","first-page":"245","article-title":"Prolonged survival in a patient with pulmonary metastases of a malignant pheochromocytoma","volume":"21","author":"van den Broek","year":"1978","journal-title":"Neth J Med"},{"key":"10.1016\/j.soc.2006.05.009_bib29","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.soc.2006.05.009_bib30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","article-title":"Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features","volume":"21","author":"Linnoila","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1600-0463.2004.apm1120901.x","article-title":"Malignancy in pheochromocytomas","volume":"112","author":"Salmenkivi","year":"2004","journal-title":"APMIS"},{"key":"10.1016\/j.soc.2006.05.009_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2559.1991.tb00877.x","article-title":"Immunocytochemistry of paragangliomas\u2013value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis","volume":"18","author":"Achilles","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.soc.2006.05.009_bib33","first-page":"484","article-title":"S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas","volume":"115","author":"Unger","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.soc.2006.05.009_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2559.2003.01645.x","article-title":"Lack of histologically suspicious features, proliferative activity, and p53 expression suggests benign diagnosis in phaeochromocytomas","volume":"43","author":"Salmenkivi","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.soc.2006.05.009_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<176::AID-CNCR22>3.0.CO;2-Z","article-title":"Elevated levels of telomerase activity in malignant pheochromocytoma","volume":"82","author":"Kubota","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.009_bib37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MP.0000056982.07160.E3","article-title":"KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma","volume":"16","author":"Elder","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib38","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1210\/jc.2002-021299","article-title":"Expression profile of the telomeric complex discriminates between benign and malignant pheochromocytoma","volume":"88","author":"Boltze","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.009_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1679\/aohc.61.17","article-title":"Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat","volume":"61","author":"Fan","year":"1998","journal-title":"Arch Histol Cytol"},{"key":"10.1016\/j.soc.2006.05.009_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005537-200001000-00029","article-title":"Expression of angiogenic growth factors in paragangliomas","volume":"110","author":"Jyung","year":"2000","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2006.05.009_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ijc.20670","article-title":"Downregulation of metastasis suppressor genes in malignant pheochromocytoma","volume":"114","author":"Ohta","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2006.05.009_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/10455","article-title":"Heparanase: breaking down barriers in tumors","volume":"5","author":"Eccles","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.soc.2006.05.009_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/jsre.2002.6451","article-title":"Differential heparanase-1 expression in malignant and benign pheochromocytomas","volume":"108","author":"Quiros","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.soc.2006.05.009_bib44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00000478-200111000-00010","article-title":"Increased expression of tenascin in pheochromocytomas correlates with malignancy","volume":"25","author":"Salmenkivi","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.soc.2006.05.009_bib45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.soc.2006.05.009_bib46","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1210\/jcem.86.11.8052","article-title":"Increased expression of cyclooxygenase-2 in malignant pheochromocytomas","volume":"86","author":"Salmenkivi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.soc.2006.05.009_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1507\/endocrj1954.32.337","article-title":"A malignant pheochromocytoma with ileus, polyuria and hypercalcemia: a case of recurrence 17 years after the initial operation","volume":"32","author":"Baba","year":"1985","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.soc.2006.05.009_bib48","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2169\/internalmedicine.32.789","article-title":"Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion","volume":"32","author":"Tanaka","year":"1993","journal-title":"Intern Med"},{"key":"10.1016\/j.soc.2006.05.009_bib49","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000074663","article-title":"Malignant pheochromocytoma","volume":"31","author":"Lehnert","year":"2004","journal-title":"Front Horm Res"},{"key":"10.1016\/j.soc.2006.05.009_bib50","first-page":"1193","article-title":"Reversal of catecholamine induced cardiomyopathy in a patient with bilateral malignant pheochromocytoma","volume":"49","author":"Agarwal","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.soc.2006.05.009_bib51","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF03218106","article-title":"Surgical excision of malignant pheochromocytoma in the left atrium","volume":"48","author":"Nonaka","year":"2000","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2006.05.009_bib52","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s00268-004-7620-0","article-title":"Reasons for conversion from laparoscopic to open or hand-assisted adrenalectomy: review of 261 laparoscopic adrenalectomies from 1993 to 2003","volume":"28","author":"Shen","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.soc.2006.05.009_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine","volume":"109","author":"Averbuch","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.soc.2006.05.009_bib54","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdg358","article-title":"Successful treatment of malignant pheochromocytoma with combination chemotherapy containing anthracycline","volume":"14","author":"Nakane","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2006.05.009_bib55","article-title":"A phase II study of thalidomide in metastatic neuroendocrine tumors","author":"Xu","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.soc.2006.05.009_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2005.03.6046","article-title":"Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors","volume":"24","author":"Kulke","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soc.2006.05.009_bib57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/cncr.11518","article-title":"High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma","volume":"98","author":"Rose","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2006.05.009_bib58","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0039-6060(03)00426-4","article-title":"Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma","volume":"134","author":"Safford","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2006.05.009_bib59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF03345807","article-title":"Malignant pheochromocytoma: clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases","volume":"15","author":"Schlumberger","year":"1992","journal-title":"J Endocrinol Invest"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320706000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320706000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:52:27Z","timestamp":1760961147000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320706000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1055320706000263"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2006.05.009","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignant Pheochromocytoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2006.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}